Rhythm Pharmaceuticals (RYTM) Cash from Operations (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Cash from Operations of 44185000.0 for Q1 2026, down 9.5% year-over-year from 48824080.15 in Q1 2025, and down 74.03% quarter-over-quarter from 25389000.0 in Q4 2025.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Cash from Operations (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Cash from Operations for 11 consecutive years, with 44185000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 9.5% year-over-year to 44185000.0; the TTM figure through Mar 2026 stood at 119509000.0 (down 5.31% YoY), while the FY2025 annual figure was 115675000.0, down 1.58% from the prior year.
- Cash from Operations slipped to 44185000.0 in Q1 2026 per RYTM's latest filing, from 25389000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 18845000.0 in Q4 2024 and bottomed at 53632000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 34313176.47 across 5 years, with a median of 34000000.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 59.95% — and 2023, when it surged 37.75%.
- Rhythm Pharmaceuticals' Cash from Operations stood at 34000000.0 in 2022, then advanced by 13.58% to 29383000.0 in 2023, then soared by 35.86% to 18845000.0 in 2024, then plunged by 34.73% to 25389000.0 in 2025, then slumped by 74.03% to 44185000.0 in 2026.
- Business Quant data shows RYTM's Cash from Operations at 44185000.0 in Q1 2026, 25389000.0 in Q4 2025, and 26622000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Rhythm Pharmaceuticals | 7.05 Bn | 6.72 Bn | 62.32 Mn | -9.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.15 Mn |
| Mar 31, 2026 | -44.19 Mn |
| Dec 31, 2025 | -25.39 Mn |
| Sep 30, 2025 | -26.62 Mn |
| Jun 30, 2025 | -23.31 Mn |
| Mar 31, 2025 | -40.35 Mn |
| Dec 31, 2024 | -18.85 Mn |
| Sep 30, 2024 | -25.22 Mn |
| Jun 30, 2024 | -29.08 Mn |
| Mar 31, 2024 | -40.74 Mn |
| Dec 31, 2023 | -29.38 Mn |
| Sep 30, 2023 | -29.25 Mn |
| Jun 30, 2023 | -41.09 Mn |
| Mar 31, 2023 | -36.43 Mn |
| Dec 31, 2022 | -34.00 Mn |
| Sep 30, 2022 | -46.99 Mn |
| Jun 30, 2022 | -38.81 Mn |
| Mar 31, 2022 | -53.63 Mn |
| Dec 31, 2021 | -40.47 Mn |
| Sep 30, 2021 | -40.16 Mn |